KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Other Non-Current Liabilities (2017 - 2025)

Historic Other Non-Current Liabilities for Elanco Animal Health (ELAN) over the last 9 years, with Q3 2025 value amounting to $607.0 million.

  • Elanco Animal Health's Other Non-Current Liabilities rose 340.72% to $607.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $607.0 million, marking a year-over-year increase of 340.72%. This contributed to the annual value of $477.0 million for FY2024, which is 1605.84% up from last year.
  • According to the latest figures from Q3 2025, Elanco Animal Health's Other Non-Current Liabilities is $607.0 million, which was up 340.72% from $638.0 million recorded in Q2 2025.
  • Over the past 5 years, Elanco Animal Health's Other Non-Current Liabilities peaked at $638.0 million during Q2 2025, and registered a low of $220.0 million during Q3 2021.
  • For the 5-year period, Elanco Animal Health's Other Non-Current Liabilities averaged around $375.7 million, with its median value being $411.0 million (2023).
  • In the last 5 years, Elanco Animal Health's Other Non-Current Liabilities tumbled by 2969.0% in 2021 and then surged by 9346.94% in 2024.
  • Elanco Animal Health's Other Non-Current Liabilities (Quarter) stood at $262.0 million in 2021, then decreased by 12.6% to $229.0 million in 2022, then skyrocketed by 79.48% to $411.0 million in 2023, then grew by 16.06% to $477.0 million in 2024, then increased by 27.25% to $607.0 million in 2025.
  • Its last three reported values are $607.0 million in Q3 2025, $638.0 million for Q2 2025, and $487.0 million during Q1 2025.